πŸ‡ΊπŸ‡Έ FDA
Patent

US 10538579

Bispecific pertussis antibodies

granted A61KA61K2039/505A61P

Quick answer

US patent 10538579 (Bispecific pertussis antibodies) held by The Board of Regents of the University of Texas System expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61P, A61P31/04